Global Bacterial Vaccines for Humans Supply, Demand and Key Producers, 2024-2030
The global Bacterial Vaccines for Humans market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
This report studies the global Bacterial Vaccines for Humans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bacterial Vaccines for Humans, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacterial Vaccines for Humans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bacterial Vaccines for Humans total production and demand, 2019-2030, (K Units)
Global Bacterial Vaccines for Humans total production value, 2019-2030, (USD Million)
Global Bacterial Vaccines for Humans production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Bacterial Vaccines for Humans domestic production, consumption, key domestic manufacturers and share
Global Bacterial Vaccines for Humans production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Bacterial Vaccines for Humans market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions, Walvax and Chengdu Kanghua Biological Products Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacterial Vaccines for Humans market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Bacterial Vaccines for Humans Market, By Region:
1. How big is the global Bacterial Vaccines for Humans market?
2. What is the demand of the global Bacterial Vaccines for Humans market?
3. What is the year over year growth of the global Bacterial Vaccines for Humans market?
4. What is the production and production value of the global Bacterial Vaccines for Humans market?
5. Who are the key producers in the global Bacterial Vaccines for Humans market?
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
This report studies the global Bacterial Vaccines for Humans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bacterial Vaccines for Humans, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bacterial Vaccines for Humans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bacterial Vaccines for Humans total production and demand, 2019-2030, (K Units)
Global Bacterial Vaccines for Humans total production value, 2019-2030, (USD Million)
Global Bacterial Vaccines for Humans production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Bacterial Vaccines for Humans domestic production, consumption, key domestic manufacturers and share
Global Bacterial Vaccines for Humans production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Bacterial Vaccines for Humans production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Bacterial Vaccines for Humans market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions, Walvax and Chengdu Kanghua Biological Products Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Bacterial Vaccines for Humans market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Bacterial Vaccines for Humans Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Meningococcal Vaccine
- Hib Vaccine
- BCG Vaccine
- Typhoid Vaccine
- Anthrax Vaccine
- Hospital
- Clinic
- Others
- Merck
- Sanofi
- GSK
- Mitsubishi Tanabe Pharma
- Pfizer
- Bayer
- Emergent BioSolutions
- Walvax
- Chengdu Kanghua Biological Products Co., Ltd.
- Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
- Beijing Institute of Biological Products Co., Ltd.
- CanSino Biological Co., Ltd.
- Hualan Biological Vaccine Co., Ltd.
- Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
1. How big is the global Bacterial Vaccines for Humans market?
2. What is the demand of the global Bacterial Vaccines for Humans market?
3. What is the year over year growth of the global Bacterial Vaccines for Humans market?
4. What is the production and production value of the global Bacterial Vaccines for Humans market?
5. Who are the key producers in the global Bacterial Vaccines for Humans market?
1 SUPPLY SUMMARY
1.1 Bacterial Vaccines for Humans Introduction
1.2 World Bacterial Vaccines for Humans Supply & Forecast
1.2.1 World Bacterial Vaccines for Humans Production Value (2019 & 2023 & 2030)
1.2.2 World Bacterial Vaccines for Humans Production (2019-2030)
1.2.3 World Bacterial Vaccines for Humans Pricing Trends (2019-2030)
1.3 World Bacterial Vaccines for Humans Production by Region (Based on Production Site)
1.3.1 World Bacterial Vaccines for Humans Production Value by Region (2019-2030)
1.3.2 World Bacterial Vaccines for Humans Production by Region (2019-2030)
1.3.3 World Bacterial Vaccines for Humans Average Price by Region (2019-2030)
1.3.4 North America Bacterial Vaccines for Humans Production (2019-2030)
1.3.5 Europe Bacterial Vaccines for Humans Production (2019-2030)
1.3.6 China Bacterial Vaccines for Humans Production (2019-2030)
1.3.7 Japan Bacterial Vaccines for Humans Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bacterial Vaccines for Humans Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bacterial Vaccines for Humans Major Market Trends
2 DEMAND SUMMARY
2.1 World Bacterial Vaccines for Humans Demand (2019-2030)
2.2 World Bacterial Vaccines for Humans Consumption by Region
2.2.1 World Bacterial Vaccines for Humans Consumption by Region (2019-2024)
2.2.2 World Bacterial Vaccines for Humans Consumption Forecast by Region (2025-2030)
2.3 United States Bacterial Vaccines for Humans Consumption (2019-2030)
2.4 China Bacterial Vaccines for Humans Consumption (2019-2030)
2.5 Europe Bacterial Vaccines for Humans Consumption (2019-2030)
2.6 Japan Bacterial Vaccines for Humans Consumption (2019-2030)
2.7 South Korea Bacterial Vaccines for Humans Consumption (2019-2030)
2.8 ASEAN Bacterial Vaccines for Humans Consumption (2019-2030)
2.9 India Bacterial Vaccines for Humans Consumption (2019-2030)
3 WORLD BACTERIAL VACCINES FOR HUMANS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bacterial Vaccines for Humans Production Value by Manufacturer (2019-2024)
3.2 World Bacterial Vaccines for Humans Production by Manufacturer (2019-2024)
3.3 World Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024)
3.4 Bacterial Vaccines for Humans Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bacterial Vaccines for Humans Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bacterial Vaccines for Humans in 2023
3.5.3 Global Concentration Ratios (CR8) for Bacterial Vaccines for Humans in 2023
3.6 Bacterial Vaccines for Humans Market: Overall Company Footprint Analysis
3.6.1 Bacterial Vaccines for Humans Market: Region Footprint
3.6.2 Bacterial Vaccines for Humans Market: Company Product Type Footprint
3.6.3 Bacterial Vaccines for Humans Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bacterial Vaccines for Humans Production Value Comparison
4.1.1 United States VS China: Bacterial Vaccines for Humans Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Bacterial Vaccines for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Bacterial Vaccines for Humans Production Comparison
4.2.1 United States VS China: Bacterial Vaccines for Humans Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Bacterial Vaccines for Humans Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Bacterial Vaccines for Humans Consumption Comparison
4.3.1 United States VS China: Bacterial Vaccines for Humans Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Bacterial Vaccines for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Bacterial Vaccines for Humans Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.4.3 United States Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
4.5 China Based Bacterial Vaccines for Humans Manufacturers and Market Share
4.5.1 China Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.5.3 China Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
4.6 Rest of World Based Bacterial Vaccines for Humans Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Bacterial Vaccines for Humans Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Meningococcal Vaccine
5.2.2 Hib Vaccine
5.2.3 BCG Vaccine
5.2.4 Typhoid Vaccine
5.2.5 Anthrax Vaccine
5.3 Market Segment by Type
5.3.1 World Bacterial Vaccines for Humans Production by Type (2019-2030)
5.3.2 World Bacterial Vaccines for Humans Production Value by Type (2019-2030)
5.3.3 World Bacterial Vaccines for Humans Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Bacterial Vaccines for Humans Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Bacterial Vaccines for Humans Production by Application (2019-2030)
6.3.2 World Bacterial Vaccines for Humans Production Value by Application (2019-2030)
6.3.3 World Bacterial Vaccines for Humans Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Bacterial Vaccines for Humans Product and Services
7.1.4 Merck Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Bacterial Vaccines for Humans Product and Services
7.2.4 Sanofi Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Bacterial Vaccines for Humans Product and Services
7.3.4 GSK Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Mitsubishi Tanabe Pharma
7.4.1 Mitsubishi Tanabe Pharma Details
7.4.2 Mitsubishi Tanabe Pharma Major Business
7.4.3 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
7.4.4 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.4.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Bacterial Vaccines for Humans Product and Services
7.5.4 Pfizer Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Bayer
7.6.1 Bayer Details
7.6.2 Bayer Major Business
7.6.3 Bayer Bacterial Vaccines for Humans Product and Services
7.6.4 Bayer Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bayer Recent Developments/Updates
7.6.6 Bayer Competitive Strengths & Weaknesses
7.7 Emergent BioSolutions
7.7.1 Emergent BioSolutions Details
7.7.2 Emergent BioSolutions Major Business
7.7.3 Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
7.7.4 Emergent BioSolutions Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Emergent BioSolutions Recent Developments/Updates
7.7.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.8 Walvax
7.8.1 Walvax Details
7.8.2 Walvax Major Business
7.8.3 Walvax Bacterial Vaccines for Humans Product and Services
7.8.4 Walvax Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Walvax Recent Developments/Updates
7.8.6 Walvax Competitive Strengths & Weaknesses
7.9 Chengdu Kanghua Biological Products Co., Ltd.
7.9.1 Chengdu Kanghua Biological Products Co., Ltd. Details
7.9.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
7.9.3 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.9.4 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
7.9.6 Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.10 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
7.10.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
7.10.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
7.10.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
7.11.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
7.11.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
7.11.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.11.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Beijing Institute of Biological Products Co., Ltd.
7.12.1 Beijing Institute of Biological Products Co., Ltd. Details
7.12.2 Beijing Institute of Biological Products Co., Ltd. Major Business
7.12.3 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.12.4 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
7.12.6 Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.13 CanSino Biological Co., Ltd.
7.13.1 CanSino Biological Co., Ltd. Details
7.13.2 CanSino Biological Co., Ltd. Major Business
7.13.3 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.13.4 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 CanSino Biological Co., Ltd. Recent Developments/Updates
7.13.6 CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
7.14 Hualan Biological Vaccine Co., Ltd.
7.14.1 Hualan Biological Vaccine Co., Ltd. Details
7.14.2 Hualan Biological Vaccine Co., Ltd. Major Business
7.14.3 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.14.4 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
7.14.6 Hualan Biological Vaccine Co., Ltd. Competitive Strengths & Weaknesses
7.15 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
7.15.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
7.15.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
7.15.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.15.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
7.15.6 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Bacterial Vaccines for Humans Industry Chain
8.2 Bacterial Vaccines for Humans Upstream Analysis
8.2.1 Bacterial Vaccines for Humans Core Raw Materials
8.2.2 Main Manufacturers of Bacterial Vaccines for Humans Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Bacterial Vaccines for Humans Production Mode
8.6 Bacterial Vaccines for Humans Procurement Model
8.7 Bacterial Vaccines for Humans Industry Sales Model and Sales Channels
8.7.1 Bacterial Vaccines for Humans Sales Model
8.7.2 Bacterial Vaccines for Humans Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Bacterial Vaccines for Humans Introduction
1.2 World Bacterial Vaccines for Humans Supply & Forecast
1.2.1 World Bacterial Vaccines for Humans Production Value (2019 & 2023 & 2030)
1.2.2 World Bacterial Vaccines for Humans Production (2019-2030)
1.2.3 World Bacterial Vaccines for Humans Pricing Trends (2019-2030)
1.3 World Bacterial Vaccines for Humans Production by Region (Based on Production Site)
1.3.1 World Bacterial Vaccines for Humans Production Value by Region (2019-2030)
1.3.2 World Bacterial Vaccines for Humans Production by Region (2019-2030)
1.3.3 World Bacterial Vaccines for Humans Average Price by Region (2019-2030)
1.3.4 North America Bacterial Vaccines for Humans Production (2019-2030)
1.3.5 Europe Bacterial Vaccines for Humans Production (2019-2030)
1.3.6 China Bacterial Vaccines for Humans Production (2019-2030)
1.3.7 Japan Bacterial Vaccines for Humans Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bacterial Vaccines for Humans Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Bacterial Vaccines for Humans Major Market Trends
2 DEMAND SUMMARY
2.1 World Bacterial Vaccines for Humans Demand (2019-2030)
2.2 World Bacterial Vaccines for Humans Consumption by Region
2.2.1 World Bacterial Vaccines for Humans Consumption by Region (2019-2024)
2.2.2 World Bacterial Vaccines for Humans Consumption Forecast by Region (2025-2030)
2.3 United States Bacterial Vaccines for Humans Consumption (2019-2030)
2.4 China Bacterial Vaccines for Humans Consumption (2019-2030)
2.5 Europe Bacterial Vaccines for Humans Consumption (2019-2030)
2.6 Japan Bacterial Vaccines for Humans Consumption (2019-2030)
2.7 South Korea Bacterial Vaccines for Humans Consumption (2019-2030)
2.8 ASEAN Bacterial Vaccines for Humans Consumption (2019-2030)
2.9 India Bacterial Vaccines for Humans Consumption (2019-2030)
3 WORLD BACTERIAL VACCINES FOR HUMANS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Bacterial Vaccines for Humans Production Value by Manufacturer (2019-2024)
3.2 World Bacterial Vaccines for Humans Production by Manufacturer (2019-2024)
3.3 World Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024)
3.4 Bacterial Vaccines for Humans Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Bacterial Vaccines for Humans Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Bacterial Vaccines for Humans in 2023
3.5.3 Global Concentration Ratios (CR8) for Bacterial Vaccines for Humans in 2023
3.6 Bacterial Vaccines for Humans Market: Overall Company Footprint Analysis
3.6.1 Bacterial Vaccines for Humans Market: Region Footprint
3.6.2 Bacterial Vaccines for Humans Market: Company Product Type Footprint
3.6.3 Bacterial Vaccines for Humans Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Bacterial Vaccines for Humans Production Value Comparison
4.1.1 United States VS China: Bacterial Vaccines for Humans Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Bacterial Vaccines for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Bacterial Vaccines for Humans Production Comparison
4.2.1 United States VS China: Bacterial Vaccines for Humans Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Bacterial Vaccines for Humans Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Bacterial Vaccines for Humans Consumption Comparison
4.3.1 United States VS China: Bacterial Vaccines for Humans Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Bacterial Vaccines for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Bacterial Vaccines for Humans Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.4.3 United States Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
4.5 China Based Bacterial Vaccines for Humans Manufacturers and Market Share
4.5.1 China Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.5.3 China Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
4.6 Rest of World Based Bacterial Vaccines for Humans Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Bacterial Vaccines for Humans Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Meningococcal Vaccine
5.2.2 Hib Vaccine
5.2.3 BCG Vaccine
5.2.4 Typhoid Vaccine
5.2.5 Anthrax Vaccine
5.3 Market Segment by Type
5.3.1 World Bacterial Vaccines for Humans Production by Type (2019-2030)
5.3.2 World Bacterial Vaccines for Humans Production Value by Type (2019-2030)
5.3.3 World Bacterial Vaccines for Humans Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Bacterial Vaccines for Humans Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Bacterial Vaccines for Humans Production by Application (2019-2030)
6.3.2 World Bacterial Vaccines for Humans Production Value by Application (2019-2030)
6.3.3 World Bacterial Vaccines for Humans Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Bacterial Vaccines for Humans Product and Services
7.1.4 Merck Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Bacterial Vaccines for Humans Product and Services
7.2.4 Sanofi Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Bacterial Vaccines for Humans Product and Services
7.3.4 GSK Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Mitsubishi Tanabe Pharma
7.4.1 Mitsubishi Tanabe Pharma Details
7.4.2 Mitsubishi Tanabe Pharma Major Business
7.4.3 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
7.4.4 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.4.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Bacterial Vaccines for Humans Product and Services
7.5.4 Pfizer Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Bayer
7.6.1 Bayer Details
7.6.2 Bayer Major Business
7.6.3 Bayer Bacterial Vaccines for Humans Product and Services
7.6.4 Bayer Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bayer Recent Developments/Updates
7.6.6 Bayer Competitive Strengths & Weaknesses
7.7 Emergent BioSolutions
7.7.1 Emergent BioSolutions Details
7.7.2 Emergent BioSolutions Major Business
7.7.3 Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
7.7.4 Emergent BioSolutions Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Emergent BioSolutions Recent Developments/Updates
7.7.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.8 Walvax
7.8.1 Walvax Details
7.8.2 Walvax Major Business
7.8.3 Walvax Bacterial Vaccines for Humans Product and Services
7.8.4 Walvax Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Walvax Recent Developments/Updates
7.8.6 Walvax Competitive Strengths & Weaknesses
7.9 Chengdu Kanghua Biological Products Co., Ltd.
7.9.1 Chengdu Kanghua Biological Products Co., Ltd. Details
7.9.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
7.9.3 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.9.4 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
7.9.6 Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.10 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
7.10.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
7.10.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
7.10.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
7.11.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
7.11.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
7.11.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.11.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Beijing Institute of Biological Products Co., Ltd.
7.12.1 Beijing Institute of Biological Products Co., Ltd. Details
7.12.2 Beijing Institute of Biological Products Co., Ltd. Major Business
7.12.3 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.12.4 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
7.12.6 Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.13 CanSino Biological Co., Ltd.
7.13.1 CanSino Biological Co., Ltd. Details
7.13.2 CanSino Biological Co., Ltd. Major Business
7.13.3 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.13.4 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 CanSino Biological Co., Ltd. Recent Developments/Updates
7.13.6 CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
7.14 Hualan Biological Vaccine Co., Ltd.
7.14.1 Hualan Biological Vaccine Co., Ltd. Details
7.14.2 Hualan Biological Vaccine Co., Ltd. Major Business
7.14.3 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.14.4 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
7.14.6 Hualan Biological Vaccine Co., Ltd. Competitive Strengths & Weaknesses
7.15 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
7.15.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
7.15.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
7.15.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
7.15.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
7.15.6 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Bacterial Vaccines for Humans Industry Chain
8.2 Bacterial Vaccines for Humans Upstream Analysis
8.2.1 Bacterial Vaccines for Humans Core Raw Materials
8.2.2 Main Manufacturers of Bacterial Vaccines for Humans Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Bacterial Vaccines for Humans Production Mode
8.6 Bacterial Vaccines for Humans Procurement Model
8.7 Bacterial Vaccines for Humans Industry Sales Model and Sales Channels
8.7.1 Bacterial Vaccines for Humans Sales Model
8.7.2 Bacterial Vaccines for Humans Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Bacterial Vaccines for Humans Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Bacterial Vaccines for Humans Production Value by Region (2019-2024) & (USD Million)
Table 3. World Bacterial Vaccines for Humans Production Value by Region (2025-2030) & (USD Million)
Table 4. World Bacterial Vaccines for Humans Production Value Market Share by Region (2019-2024)
Table 5. World Bacterial Vaccines for Humans Production Value Market Share by Region (2025-2030)
Table 6. World Bacterial Vaccines for Humans Production by Region (2019-2024) & (K Units)
Table 7. World Bacterial Vaccines for Humans Production by Region (2025-2030) & (K Units)
Table 8. World Bacterial Vaccines for Humans Production Market Share by Region (2019-2024)
Table 9. World Bacterial Vaccines for Humans Production Market Share by Region (2025-2030)
Table 10. World Bacterial Vaccines for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Bacterial Vaccines for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Bacterial Vaccines for Humans Major Market Trends
Table 13. World Bacterial Vaccines for Humans Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Bacterial Vaccines for Humans Consumption by Region (2019-2024) & (K Units)
Table 15. World Bacterial Vaccines for Humans Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Bacterial Vaccines for Humans Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Bacterial Vaccines for Humans Producers in 2023
Table 18. World Bacterial Vaccines for Humans Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Bacterial Vaccines for Humans Producers in 2023
Table 20. World Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Bacterial Vaccines for Humans Company Evaluation Quadrant
Table 22. World Bacterial Vaccines for Humans Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Bacterial Vaccines for Humans Production Site of Key Manufacturer
Table 24. Bacterial Vaccines for Humans Market: Company Product Type Footprint
Table 25. Bacterial Vaccines for Humans Market: Company Product Application Footprint
Table 26. Bacterial Vaccines for Humans Competitive Factors
Table 27. Bacterial Vaccines for Humans New Entrant and Capacity Expansion Plans
Table 28. Bacterial Vaccines for Humans Mergers & Acquisitions Activity
Table 29. United States VS China Bacterial Vaccines for Humans Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Bacterial Vaccines for Humans Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Bacterial Vaccines for Humans Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 37. China Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 42. Rest of World Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 47. World Bacterial Vaccines for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Bacterial Vaccines for Humans Production by Type (2019-2024) & (K Units)
Table 49. World Bacterial Vaccines for Humans Production by Type (2025-2030) & (K Units)
Table 50. World Bacterial Vaccines for Humans Production Value by Type (2019-2024) & (USD Million)
Table 51. World Bacterial Vaccines for Humans Production Value by Type (2025-2030) & (USD Million)
Table 52. World Bacterial Vaccines for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Bacterial Vaccines for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Bacterial Vaccines for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Bacterial Vaccines for Humans Production by Application (2019-2024) & (K Units)
Table 56. World Bacterial Vaccines for Humans Production by Application (2025-2030) & (K Units)
Table 57. World Bacterial Vaccines for Humans Production Value by Application (2019-2024) & (USD Million)
Table 58. World Bacterial Vaccines for Humans Production Value by Application (2025-2030) & (USD Million)
Table 59. World Bacterial Vaccines for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Bacterial Vaccines for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Bacterial Vaccines for Humans Product and Services
Table 64. Merck Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Bacterial Vaccines for Humans Product and Services
Table 70. Sanofi Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Bacterial Vaccines for Humans Product and Services
Table 76. GSK Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Mitsubishi Tanabe Pharma Major Business
Table 81. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
Table 82. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 84. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Bacterial Vaccines for Humans Product and Services
Table 88. Pfizer Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Bayer Basic Information, Manufacturing Base and Competitors
Table 92. Bayer Major Business
Table 93. Bayer Bacterial Vaccines for Humans Product and Services
Table 94. Bayer Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bayer Recent Developments/Updates
Table 96. Bayer Competitive Strengths & Weaknesses
Table 97. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 98. Emergent BioSolutions Major Business
Table 99. Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
Table 100. Emergent BioSolutions Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Emergent BioSolutions Recent Developments/Updates
Table 102. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 103. Walvax Basic Information, Manufacturing Base and Competitors
Table 104. Walvax Major Business
Table 105. Walvax Bacterial Vaccines for Humans Product and Services
Table 106. Walvax Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Walvax Recent Developments/Updates
Table 108. Walvax Competitive Strengths & Weaknesses
Table 109. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 111. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 112. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 114. Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 115. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 117. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 118. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 121. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 123. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 124. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 127. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 129. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 130. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 132. Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 133. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. CanSino Biological Co., Ltd. Major Business
Table 135. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 136. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 138. CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Hualan Biological Vaccine Co., Ltd. Major Business
Table 141. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 142. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 144. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 145. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 146. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 147. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 148. Global Key Players of Bacterial Vaccines for Humans Upstream (Raw Materials)
Table 149. Bacterial Vaccines for Humans Typical Customers
Table 150. Bacterial Vaccines for Humans Typical Distributors
LIST OF FIGURE
Figure 1. Bacterial Vaccines for Humans Picture
Figure 2. World Bacterial Vaccines for Humans Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Bacterial Vaccines for Humans Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 5. World Bacterial Vaccines for Humans Average Price (2019-2030) & (US$/Unit)
Figure 6. World Bacterial Vaccines for Humans Production Value Market Share by Region (2019-2030)
Figure 7. World Bacterial Vaccines for Humans Production Market Share by Region (2019-2030)
Figure 8. North America Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 9. Europe Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 10. China Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 11. Japan Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 12. Bacterial Vaccines for Humans Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 15. World Bacterial Vaccines for Humans Consumption Market Share by Region (2019-2030)
Figure 16. United States Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 17. China Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 18. Europe Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 19. Japan Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 20. South Korea Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 22. India Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bacterial Vaccines for Humans Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bacterial Vaccines for Humans Markets in 2023
Figure 26. United States VS China: Bacterial Vaccines for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Bacterial Vaccines for Humans Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Bacterial Vaccines for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 30. China Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 32. World Bacterial Vaccines for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Bacterial Vaccines for Humans Production Value Market Share by Type in 2023
Figure 34. Meningococcal Vaccine
Figure 35. Hib Vaccine
Figure 36. BCG Vaccine
Figure 37. Typhoid Vaccine
Figure 38. Anthrax Vaccine
Figure 39. World Bacterial Vaccines for Humans Production Market Share by Type (2019-2030)
Figure 40. World Bacterial Vaccines for Humans Production Value Market Share by Type (2019-2030)
Figure 41. World Bacterial Vaccines for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 42. World Bacterial Vaccines for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Bacterial Vaccines for Humans Production Value Market Share by Application in 2023
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Others
Figure 47. World Bacterial Vaccines for Humans Production Market Share by Application (2019-2030)
Figure 48. World Bacterial Vaccines for Humans Production Value Market Share by Application (2019-2030)
Figure 49. World Bacterial Vaccines for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 50. Bacterial Vaccines for Humans Industry Chain
Figure 51. Bacterial Vaccines for Humans Procurement Model
Figure 52. Bacterial Vaccines for Humans Sales Model
Figure 53. Bacterial Vaccines for Humans Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Bacterial Vaccines for Humans Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Bacterial Vaccines for Humans Production Value by Region (2019-2024) & (USD Million)
Table 3. World Bacterial Vaccines for Humans Production Value by Region (2025-2030) & (USD Million)
Table 4. World Bacterial Vaccines for Humans Production Value Market Share by Region (2019-2024)
Table 5. World Bacterial Vaccines for Humans Production Value Market Share by Region (2025-2030)
Table 6. World Bacterial Vaccines for Humans Production by Region (2019-2024) & (K Units)
Table 7. World Bacterial Vaccines for Humans Production by Region (2025-2030) & (K Units)
Table 8. World Bacterial Vaccines for Humans Production Market Share by Region (2019-2024)
Table 9. World Bacterial Vaccines for Humans Production Market Share by Region (2025-2030)
Table 10. World Bacterial Vaccines for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Bacterial Vaccines for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Bacterial Vaccines for Humans Major Market Trends
Table 13. World Bacterial Vaccines for Humans Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Bacterial Vaccines for Humans Consumption by Region (2019-2024) & (K Units)
Table 15. World Bacterial Vaccines for Humans Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Bacterial Vaccines for Humans Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Bacterial Vaccines for Humans Producers in 2023
Table 18. World Bacterial Vaccines for Humans Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Bacterial Vaccines for Humans Producers in 2023
Table 20. World Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Bacterial Vaccines for Humans Company Evaluation Quadrant
Table 22. World Bacterial Vaccines for Humans Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Bacterial Vaccines for Humans Production Site of Key Manufacturer
Table 24. Bacterial Vaccines for Humans Market: Company Product Type Footprint
Table 25. Bacterial Vaccines for Humans Market: Company Product Application Footprint
Table 26. Bacterial Vaccines for Humans Competitive Factors
Table 27. Bacterial Vaccines for Humans New Entrant and Capacity Expansion Plans
Table 28. Bacterial Vaccines for Humans Mergers & Acquisitions Activity
Table 29. United States VS China Bacterial Vaccines for Humans Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Bacterial Vaccines for Humans Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Bacterial Vaccines for Humans Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 37. China Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 42. Rest of World Based Bacterial Vaccines for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Market Share (2019-2024)
Table 47. World Bacterial Vaccines for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Bacterial Vaccines for Humans Production by Type (2019-2024) & (K Units)
Table 49. World Bacterial Vaccines for Humans Production by Type (2025-2030) & (K Units)
Table 50. World Bacterial Vaccines for Humans Production Value by Type (2019-2024) & (USD Million)
Table 51. World Bacterial Vaccines for Humans Production Value by Type (2025-2030) & (USD Million)
Table 52. World Bacterial Vaccines for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Bacterial Vaccines for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Bacterial Vaccines for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Bacterial Vaccines for Humans Production by Application (2019-2024) & (K Units)
Table 56. World Bacterial Vaccines for Humans Production by Application (2025-2030) & (K Units)
Table 57. World Bacterial Vaccines for Humans Production Value by Application (2019-2024) & (USD Million)
Table 58. World Bacterial Vaccines for Humans Production Value by Application (2025-2030) & (USD Million)
Table 59. World Bacterial Vaccines for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Bacterial Vaccines for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Bacterial Vaccines for Humans Product and Services
Table 64. Merck Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Bacterial Vaccines for Humans Product and Services
Table 70. Sanofi Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Bacterial Vaccines for Humans Product and Services
Table 76. GSK Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Mitsubishi Tanabe Pharma Major Business
Table 81. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
Table 82. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 84. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Bacterial Vaccines for Humans Product and Services
Table 88. Pfizer Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Bayer Basic Information, Manufacturing Base and Competitors
Table 92. Bayer Major Business
Table 93. Bayer Bacterial Vaccines for Humans Product and Services
Table 94. Bayer Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bayer Recent Developments/Updates
Table 96. Bayer Competitive Strengths & Weaknesses
Table 97. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 98. Emergent BioSolutions Major Business
Table 99. Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
Table 100. Emergent BioSolutions Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Emergent BioSolutions Recent Developments/Updates
Table 102. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 103. Walvax Basic Information, Manufacturing Base and Competitors
Table 104. Walvax Major Business
Table 105. Walvax Bacterial Vaccines for Humans Product and Services
Table 106. Walvax Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Walvax Recent Developments/Updates
Table 108. Walvax Competitive Strengths & Weaknesses
Table 109. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 111. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 112. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 114. Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 115. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 117. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 118. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 121. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 123. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 124. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 127. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 129. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 130. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 132. Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 133. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. CanSino Biological Co., Ltd. Major Business
Table 135. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 136. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 138. CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. Hualan Biological Vaccine Co., Ltd. Major Business
Table 141. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 142. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 144. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 145. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 146. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 147. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 148. Global Key Players of Bacterial Vaccines for Humans Upstream (Raw Materials)
Table 149. Bacterial Vaccines for Humans Typical Customers
Table 150. Bacterial Vaccines for Humans Typical Distributors
LIST OF FIGURE
Figure 1. Bacterial Vaccines for Humans Picture
Figure 2. World Bacterial Vaccines for Humans Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Bacterial Vaccines for Humans Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 5. World Bacterial Vaccines for Humans Average Price (2019-2030) & (US$/Unit)
Figure 6. World Bacterial Vaccines for Humans Production Value Market Share by Region (2019-2030)
Figure 7. World Bacterial Vaccines for Humans Production Market Share by Region (2019-2030)
Figure 8. North America Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 9. Europe Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 10. China Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 11. Japan Bacterial Vaccines for Humans Production (2019-2030) & (K Units)
Figure 12. Bacterial Vaccines for Humans Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 15. World Bacterial Vaccines for Humans Consumption Market Share by Region (2019-2030)
Figure 16. United States Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 17. China Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 18. Europe Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 19. Japan Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 20. South Korea Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 22. India Bacterial Vaccines for Humans Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Bacterial Vaccines for Humans Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Bacterial Vaccines for Humans Markets in 2023
Figure 26. United States VS China: Bacterial Vaccines for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Bacterial Vaccines for Humans Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Bacterial Vaccines for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 30. China Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Bacterial Vaccines for Humans Production Market Share 2023
Figure 32. World Bacterial Vaccines for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Bacterial Vaccines for Humans Production Value Market Share by Type in 2023
Figure 34. Meningococcal Vaccine
Figure 35. Hib Vaccine
Figure 36. BCG Vaccine
Figure 37. Typhoid Vaccine
Figure 38. Anthrax Vaccine
Figure 39. World Bacterial Vaccines for Humans Production Market Share by Type (2019-2030)
Figure 40. World Bacterial Vaccines for Humans Production Value Market Share by Type (2019-2030)
Figure 41. World Bacterial Vaccines for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 42. World Bacterial Vaccines for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Bacterial Vaccines for Humans Production Value Market Share by Application in 2023
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Others
Figure 47. World Bacterial Vaccines for Humans Production Market Share by Application (2019-2030)
Figure 48. World Bacterial Vaccines for Humans Production Value Market Share by Application (2019-2030)
Figure 49. World Bacterial Vaccines for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 50. Bacterial Vaccines for Humans Industry Chain
Figure 51. Bacterial Vaccines for Humans Procurement Model
Figure 52. Bacterial Vaccines for Humans Sales Model
Figure 53. Bacterial Vaccines for Humans Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
